COST-EFFECTIVENESS OF PEMBROLIZUMAB AS AN ADJUVANT TREATMENT FOR RENAL CELL CARCINOMA POST-NEPHRECTOMY IN FRANCE

被引：0
|
作者：
Apert, M. [1 ]
Bensimon, L. [1 ]
Marie, L. [2 ]
Chau, M. [3 ]
Baluni, G. [4 ]
Chhabra, N. [4 ]
Kundu, A. [4 ]
Bhattacharya, R. [5 ]
Lai, Y. [5 ]
Gross-Goupil, M. [6 ]
Ouzaid, I [7 ]
机构：
[1] IMSD France, Puteaux La Defense 92, France
[2] Steve Consultants, Paris, France
[3] Steve Consultants, Paris 75, France
[4] Complete HEOR Solut, N Wales, PA USA
[5] Merck & Co Inc, Rahway, NJ USA
[6] Hop St Andre, CHU Bordeaux, Bordeaux, France
[7] Hop Bichat Claude Bernard, Paris, France
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE671
引用
收藏
页码：S183 / S183
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Renal Cell Carcinoma Post-nephrectomy in the United States
    Lai, Yizhen
    Bensimon, Arielle G.
    Gao, Emily
    Bhattacharya, Rituparna
    Xu, Ruifeng
    Chevure, Jestinah
    Imai, Kentaro
    Haas, Naomi B.
    [J]. CLINICAL GENITOURINARY CANCER, 2023, 21 (05) : 612.e1 - 612.e11
  • [2] COST-EFFECTIVENESS OF PEMBROLIZUMAB FOR ADJUVANT TREATMENT OF PATIENTS WITH RENAL-CELL CARCINOMA WHO HAVE UNDERGONE NEPHRECTOMY IN COLOMBIA
    Urrego-Reyes, J.
    Arnedo, Marrugo C.
    Wurcel, V
    Jaramillo, H.
    Baluni, G.
    Mehta, S.
    Gotarkar, S.
    Bernal, L.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S83 - S83
  • [3] COST-EFFECTIVENESS ANALYSIS OF PEMBROLIZUMAB FOR THE ADJUVANT TREATMENT OF PATIENTS WITH RENAL CELL CARCINOMA WHO HAVE UNDERGONE NEPHRECTOMY IN GREECE
    Yfantopoulos, N.
    Emmanouil, G.
    Skroumpelos, A.
    Karokis, A.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S183 - S183
  • [4] Efficacy Assessment of Post-nephrectomy Adjuvant Therapies in Patients with Renal Cell Carcinoma
    Kaiyue Ding
    Zhixuan Yang
    Danyan Zhang
    Lin Sun
    [J]. Annals of Surgical Oncology, 2024, 31 : 3894 - 3905
  • [5] Efficacy Assessment of Post-nephrectomy Adjuvant Therapies in Patients with Renal Cell Carcinoma
    Ding, Kaiyue
    Yang, Zhixuan
    Zhang, Danyan
    Sun, Lin
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (6) : 3894 - 3905
  • [6] Pembrolizumab: a beacon of hope for clear-cell renal-cell carcinoma patients post-nephrectomy
    Anand, Ayush
    Banda, Godfrey T.
    Satapathy, Prakasini
    Sharma, Rakesh Kumar
    Sharma, Divya
    Arora, Mithhil
    Khatib, Mahalaqua Nazli
    Gaidhane, Shilpa
    Zahiruddin, Quazi Syed
    Rustagi, Sarvesh
    [J]. INTERNATIONAL JOURNAL OF SURGERY OPEN, 2024, 62 (04) : 493 - 495
  • [7] Pembrolizumab monotherapy for the adjuvant treatment of renal cell carcinoma post-nephrectomy: Randomized, double-blind, Phase III KEYNOTE-564 study
    Choueiri, Toni K.
    Quinn, David I.
    Zhang, Tian
    Gurney, Howard
    Doshi, Gurjyot K.
    Cobb, Patrick Wayne
    Parnis, Francis
    Lee, Jae-Lyun
    Park, Se Hoon
    Semenov, Andrey
    Thiery-Vuillemin, Antoine
    Sawrycki, Piotr
    Tomczak, Piotr
    Alekseev, Boris
    Izmailov, Adel
    Chang, Wayne Yen-Hwa
    Wan, Shuyan M.
    Poehlein, Christian Heinrich
    Willemann-Rogerio, Jaqueline
    Powles, Thomas
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [8] Cost-effectiveness of Adjuvant Pembrolizumab After Nephrectomy for High-risk Renal Cell Carcinoma: Insights for Patient Selection From a Markov Model
    Sharma, Vidit
    Wymer, Kevin M.
    Joyce, Daniel D.
    Moriarty, James
    Khanna, Abhinav
    Borah, Bijan J.
    Thompson, R. Houston
    Costello, Brian A.
    Leibovich, Bradley C.
    Boorjian, Stephen A.
    [J]. JOURNAL OF UROLOGY, 2023, 209 (01): : 89 - 97
  • [9] Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
    Sharma, Aparna
    Sahoo, Ranjit K.
    Batra, Atul
    Bleyer, Archie
    Choueiri, Toni K.
    Powles, Thomas
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (20): : 1919 - 1920
  • [10] Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
    Choueiri, T. K.
    Tomczak, P.
    Park, S. H.
    Venugopal, B.
    Ferguson, T.
    Chang, Y. -H.
    Hajek, J.
    Symeonides, S. N.
    Lee, J. L.
    Sarwar, N.
    Thiery-Vuillemin, A.
    Gross-Goupil, M.
    Mahave, M.
    Haas, N. B.
    Sawrycki, P.
    Gurney, H.
    Chevreau, C.
    Melichar, B.
    Kopyltsov, E.
    Alva, A.
    Burke, J. M.
    Doshi, G.
    Topart, D.
    Oudard, S.
    Hammers, H.
    Kitamura, H.
    Bedke, J.
    Perini, R. F.
    Zhang, P.
    Imai, K.
    Willemann-Rogerio, J.
    Quinn, D. I.
    Powles, T.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (08): : 683 - 694
12345